A Telehealth Advance Care Planning Intervention
Recruiting now · Not applicable
Conditions studied: Myeloid Malignancy, Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasm, Myelofibrosis
In brief
The objective of this project is to conduct a pilot randomized trial to assess the preliminary efficacy of a telehealth-delivered Serious Illness Care Program on healthcare communication, patient anxiety and distress, as well as completion of advance directives (specifically MOLST and healthcare proxy forms) for older patients with acute myeloid leukemia, myelodysplastic syndrome, and similar myeloid malignancies.
Key facts
- Study ID
- NCT05875805
- Run by
- University of Rochester
- People needed
- 207
- Starts
- 2024-05-20
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-04-03
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥60 years
- A diagnosis of AML, MDS, and similar myeloid malignancies (including but not limited to MDS/MPN overlap syndrome, myelofibrosis)
- Being managed in the outpatient settings
- Able to provide informed consent
- English-speaking
You may not qualify if…
- None
- Inclusion and Exclusion Criteria for Caregivers
- Inclusion criteria:
- Age ≥18 years
- Selected by patient when asked if there is a "family member, partner, friend, or caregiver with whom you discuss or who can be helpful in health-related matters"
- Able to provide informed consent
- English-speaking
- Exclusion criteria:
- None
- Inclusion and Exclusion Criteria for Oncology Providers
- Inclusion criteria:
- Oncologists and/or APPs who will be conducting the telehealth-delivered ACP visit
- Exclusion criteria:
- None
Where it is running
- University of Rochester — Rochester, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.